The date, time and location of China Biologic's presentation at the Oppenheimer 3rd Annual China Dragon Call Conference are as follows:
Date: Tuesday, May 19, 2009 Time: 10:15 p.m. to 10:45 p.m. Eastern Time Presenter: Tristan Kuo, Chief Financial Officer of China Biologic Venue: 300 Madison Avenue New York City
The China Dragon Call Conference hosted by Oppenheimer & Co. Inc. will provide intimate access to senior management of leading Chinese companies. These discussions will give investors an ability to analyze secular trends, to identify emerging opportunities and to gather insight into China's investment outlook.
All conferences are for institutional clients of Oppenheimer & Co. Inc. and are by invitation only. For more information, please contact Oppenheimer & Co. Inc. institutional sales representative.
About China Biologic Products, Inc.
China Biologic Products, Inc. (the ''Company''), through its indirect majority-owned subsidiary, Shandong Taibang Biological Products Co. Ltd., and equity investments in Xi'an Huitian Blood Products Co., Ltd. and Chongqing Dalin Biologic Technologies Co., Ltd. is currently the largest non-state-owned plasma-based biopharmaceutical company approved by the Chinese government. The Company is a fully integrated biologic products company with plasma collection, production and manufacturing, research and development, and commercial operations. The Company's blood products are irreplaceable in the application of medical emergencies, and prevention and treatment for various diseases. It sells its plasma-based biopharmaceutical products to hospitals and other healthcare facilities in China.
Safe Harbor Statement
This release may contain certain ''forward-looking statement
|SOURCE China Biologic Products, Inc.|
Copyright©2009 PR Newswire.
All rights reserved